Feb 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2015 Dec 31, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 47.05 45.78 65.00
(+2.8 pct) (-2.1 pct) (+6.5 pct)
Operating 3.79 3.34 4.50
(+13.5 pct) (-44.0 pct) (+68.0 pct)
Recurring 3.77 3.33 4.10
(+13.0 pct) (-45.1 pct) (+48.0 pct)
Net 3.34 3.16 3.30
(+5.5 pct) (-30.9 pct) (+29.0 pct)
EPS 62.79 yen 59.50 yen 62.13 yen
Ann Div 30.00 yen 30.00 yen
-Q2 div 15.00 yen 15.00 yen
-Q4 div 15.00 yen 15.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))